Leafreport finds over half CBD products mislabeled

Leafreport.com recently shared the results of its comprehensive review of the CBD products they tested during 2020-2021.

According to the findings, 60% of CBD products sent for testing had more than a 10% discount on the quantities indicated on the label.

How it works

Leafreport measures the accuracy of CBD products by comparing their labeled CBG intensity with the amount found by third-party laboratory tests. They base this accuracy on cannabinoid levels that are within 10% of what the label indicates.

Throughout 2021, the peer-reviewed watchdog shipped 221 CBD products from 111 brands for third-party testing. These include 35 CBD oil, 40 clichés, 40 groceries, 22 drinks, 55 for pets, as well as 29 coffee and tea products. To receive an A rating, products had to be within 10% of the labeled CBD content. Products that were off the label in a higher percentage received a B, C or F rating.

“Our mission was simple: send the products for third-party testing and compare the results with the amount and type of CBD listed on the product label,” said Lital Shafir, Leafreport Product Manager. “Leafreport’s goal is to help promote transparency in the CBD industry and educate consumers so that they can access safe products and deliver the advertised content. Reports like this show that the industry still has a long way to go. “We look forward to meeting consumer-friendly standards. We hope that reports like this will help educate those who want to use CBD and inform them more about their purchasing decisions.”


He reportRevealed that 28% of products received the worst grade (F) for having CBD levels that differ from the label by more than 30%. On average, the CBD content of the products was almost 25% off the label. Drinks had the worst results, with only 18% of products matching the label and two products containing no CBD. Of the 97 products advertised as containing broad or full-spectrum CBD, 44% were incorrectly labeled. In the beverage, topical and grocery categories, more products received an F than an A.

infographic-graphic-mainImage courtesy of Leafreport

“The results were quite amazing,” said Gal Shapira, Leafreport’s product manager. “We think there would be some mislabeling of some of the products, but we never expected that the vast majority of them would be mislabeled. It’s interesting to see how many products on the market just don’t contain the amount of CBD they think they have. , either too little or too much. There was even a product that contained 221% of what they advertised. “

Shapira also told NutraIngredients-USA that while the number is not necessarily high, about 44% of pet products match the strength of the labeled CBD. Shapira said the team expected that number to be much lower.


“We found that oils were the most accurate product group we tested with 74% matching the strength of labeled CBD and an average difference of only 13.5% on the label. Drinks had the worst results, with only 18% of the products matching the label and two products not containing any CBD, ”Shapira explained.

In a previous interview, Shafir told us that it is usually easier to get an accurate dosage of oils and tinctures compared to other products, so you can see that most products with an “A” rating are tinctures. and oils. “CBD drinks are difficult to formulate and contain relatively small amounts of CBD, which means variations of even a few milligrams can have a big effect,” he said.

Dragging your feet on the CBD

In April 2019, the FDA formed a working group on CBD policies. Since then, the agency has released a number of non-binding guidance documents related to CBD products. However, no regulation has been established, with the agency citing the need for further investigation.

“The differences can be attributed to the lack of evidence. Because the U.S. Food and Drug Administration (FDA) is still reviewing information on the safety and potential benefits of CBD, it makes it more difficult to regulate products within the In addition, regulations may vary from country to country, which only exacerbates the problem. That’s why we recommend that companies complete third-party testing to facilitate transparency about the content of their products, “said Shapira.

With legislation such as the Secure Banking Act of 2021, the Consumer Protection and Stabilization of the Hemp Market and CBD Derivative Hemp Act of 2021 and the Hemp Consumer Access and Security Act, Congress has the authority to address key CBD issues.

In July, Senate Majority Leader Chuck Schumer, D-NY, introduced a bill that provided a legal route for CBD supplements and directed the FDA to set a safe upper exposure limit.

Sports & Active Nutrition Summit to focus on CBD

In the area of ​​sports nutrition, advocates say CBD can help with recovery, manage inflammation after exercise, and even help improve the effects of traumatic brain injury. But what does science really say about this popular ingredient? Expert speakers at the upcoming Sports & Active Nutrition Summit, scheduled for February 14 and 16 in San Diego, will delve into this issue as well as trends in product formulation. Speakers will also explore the drawbacks of finding safe and quality sources of raw materials. Attendees will learn about the challenges these brands face and how best to meet their needs from a supplier perspective.

Make CBD Oil With ExtractCraft

Can Cannabis Help With ADHD? Benefits vs. Risks